Dean Phillips bought Vertex Pharmaceuticals Inc (NASDAQ: VRTX)
Dean Phillips (D-MN), a U.S. Representative, has disclosed 1 trade in Vertex Pharmaceuticals Inc (VRTX) since 2020, a single purchase.
The trade highlighted here is a purchase: Dean Phillips bought Unknown of Vertex Pharmaceuticals Inc (NASDAQ: VRTX) on December 18, 2020. Since that trade, VRTX is up +104.18% against the S&P 500 up +112.25%, an outperformance of -8.08%.
Data updated
Dean Phillips's VRTX trades vs the price
VRTX is up +104.18% since Dean Phillips bought on December 18, 2020, versus +112.25% for the S&P 500.
Performance since this trade
All Dean Phillips VRTX trades
Dean Phillips & VRTX trading FAQ
Is it legal for Dean Phillips to trade Vertex Pharmaceuticals Inc (VRTX) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Vertex Pharmaceuticals Inc (VRTX), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Dean Phillips buy VRTX?
Dean Phillips disclosed a purchase of Unknown of Vertex Pharmaceuticals Inc (VRTX) on December 18, 2020, according to public STOCK Act filings.
How has VRTX performed since Dean Phillips's trade?
Since Dean Phillips bought VRTX on December 18, 2020, the stock is up +104.18%, versus +112.25% for the S&P 500 over the same period, an outperformance of -8.08%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional VRTX trades?
Quantellect tracks every disclosed congressional trade in Vertex Pharmaceuticals Inc (VRTX) on the Vertex Pharmaceuticals Inc congressional trading page, which aggregates filings across all members of Congress.
Dean Phillips's VRTX tradesAll congressional filings for Vertex Pharmaceuticals IncDean Phillips's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.